ROBO1 knockdown inhibited glioma invasive, migratory, and VM-formation abilities by suppressing the expression of matrix metallopeptidase 2 (MMP2) and matrix metallopeptidase 9 (MMP9) [68]. The gene discussed is ROBO1; the disease is central nervous system cancer.